17 August 2021
Key team members of our BioMed21 collaboration will participate in panels and roundtables at WC11 –the 11th World Congress on Alternatives and Animal Use in the Life Sciences – scheduled for August 23rd-September 2nd. The staging of WC11 as a virtual event has made it possible for team members from around the world to play a part in this triennial event, originally scheduled for summer 2020. With over 100 parallel sessions, 30 exhibitors and sponsors and more than 500 e-posters, it promises to be just as vibrant and busy for participants as if it were a real-life event!
The BioMed21 collaboration is well represented at WC11. Check our schedule to find out where we are and join our sessions! Dr Brinda Poojary, our biomedical science advisor based in India, will take part in a panel discussion focused on progress in the removal of animal-based safety and toxicity tests required during vaccine production, part of a larger global harmonization initiative. This complements our efforts which culminated in the removal of the Abnormal Toxicity Test (ATT) from both the European and Indian versions of the Pharmacopoeia.